Correlation Between Biofil Chemicals and Kavveri Telecom

Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and Kavveri Telecom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and Kavveri Telecom into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and Kavveri Telecom Products, you can compare the effects of market volatilities on Biofil Chemicals and Kavveri Telecom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of Kavveri Telecom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and Kavveri Telecom.

Diversification Opportunities for Biofil Chemicals and Kavveri Telecom

0.37

Correlation Coefficient

Biofil Chemicals  Kavveri Telecom

Weak diversification

The 3 months correlation between Biofil and Kavveri is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and Kavveri Telecom Products in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kavveri Telecom Products and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with Kavveri Telecom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kavveri Telecom Products has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and Kavveri Telecom go up and down completely randomly.

Pair Corralation between Biofil Chemicals and Kavveri Telecom

Assuming the 90 days trading horizon Biofil Chemicals Pharmaceuticals is expected to under-perform the Kavveri Telecom. But the stock apears to be less risky and, when comparing its historical volatility, Biofil Chemicals Pharmaceuticals is 1.04 times less risky than Kavveri Telecom. The stock trades about -0.2 of its potential returns per unit of risk. The Kavveri Telecom Products is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  4,233  in Kavveri Telecom Products on December 1, 2024 and sell it today you would earn a total of  321.00  from holding Kavveri Telecom Products or generate 7.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Biofil Chemicals Pharmaceutica  vs.  Kavveri Telecom Products

Biofil Chemicals Pha

Risk-Adjusted Performance

Very Weak

Over the last 90 days Biofil Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Kavveri Telecom Products

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Kavveri Telecom Products are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain basic indicators, Kavveri Telecom may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Biofil Chemicals and Kavveri Telecom

The main advantage of trading using opposite Biofil Chemicals and Kavveri Telecom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, Kavveri Telecom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kavveri Telecom will offset losses from the drop in Kavveri Telecom's long position.

The idea behind Biofil Chemicals Pharmaceuticals and Kavveri Telecom Products pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.